Volume : 12, Issue : 02, February – 2025
Title:
A CASE STUDY ON DIABETES MELLITUS AROUND KRISHNAGIRI DISTRICT
Authors :
Dr. P. Udhayakumar.,M. Subash, C. Praveen, R.Thamaraiselvan, R.Vinothkumar
Abstract :
This case study explores the clinical presentation, diagnostic process and management of diabetes mellitus (DM), a chronic metabolic disorder characterized by persistent hyperglycemia resulting from defects in insulin secretion, action or both. The focus in on a type 2 Diabetes Mellitus patient, through aspects of type 1 diabetes mellitus are also briefly discussed foe comparison.
The patient a 52 years old male with a family history of diabetes presents with classic symptoms of increased thirst (polydipsia), frequent urination (polyuria), unexplained weight loss and fatigue. Upon diagnosis, the patient exhibits significantly elevated blood glucose levels, as feel as abnormal results from fasting plasma glucose (FPG), oral glucose tolerance test (OGTT), and hemoglobin A1c (HbA1c).
This study highlights the role of insulin resistance and impaired insulin secretion in the pathophysiology of T2DM, in contrast to the autoimmune destruction of beta cells seen in T1DM. The management approach for the patient includes lifestyle modifications such as diet and exercise, as well as pharmacological interventions like metformin and sulfonylureas to address insulin resistance and promote insulin secretion.
The case also addresses the importance of continuous monitoring of blood glucose levels and the need for long- term management to prevent complications such as diabetic retinopathy, nephropathy, and cardiovascular disease. The case study underscores the importance of early detection, patient education, and adherence to treatment regimens for effective diabetes management and improvement in the quality of life for individuals living with this chronic condition.
This case study serves as a valuable resource for healthcare providers in understanding the multifaceted nature of diabetes management and the complexities involved in treating patients with this condition.
Cite This Article:
Please cite this article in press P. Udhayakumar et al., A Case Study On Diabetes Mellitus Around Krishnagiri District.,Indo Am. J. P. Sci, 2025; 12 (02).
Number of Downloads : 10
References:
1. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997;20:1183 1197
2. Genuth S, Alberti KG, Bennett P, et al.; Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003;26:3160–3167
3. International Expert Committee. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 2009;32:1327 1334
4. EdelmanD,OlsenMK,DudleyTK,HarrisAC, Oddone EZ. Utility of hemoglobin A1c in predicting diabetes risk. J Gen Intern Med 2004;19:1175–1180
5. Pradhan AD, Rifai N, Buring JE, Ridker PM. Hemoglobin A1c predicts diabetes but not cardiovascular disease in nondiabetic women. Am J Med 2007;120:720–727
6. 1. World Health Organization (2007) Tuberculosis Fact Sheet. Fact Sheet No. 104. Available: http://www.who.int/mediacentre/factsheets/fs104/en/print. html. Accessed 25 September 2007.
7. Banyai A (1931) Diabetes and pulmonary tuberculosis. Am Rev Tuberc 24: 650–667.
8. RootH(1934) The association of diabetes and tuberculosis. New Engl J Med 210: 1–13.
9. Boucot KR, Dillon ES, Cooper DA, Meier P, Richardson R (1952) Tuberculosis among diabetics: the Philadelphia survey. Am Rev Tuberc 65: 1–50.
10. Nichols GP (1957) Diabetes among young tuberculous patients; a review of the association of the two diseases. Am Rev Tuberc 76: 1016–1030.
11. Pak A, Adegboye OA, Adekunle AI, Rahman KM, McBryde ES, Eisen DP. Economic Consequences of the COVID-19 outbreak: the need for epidemic preparedness. Front Public Heal. 2020;8:19. https://doi.org/10.3389/ FPUBH.2020.00241.
12. Chang AY, Cullen MR, Harrington RA, Barry M. The impact of novel coronavi rus COVID-19 on noncommunicable disease patients and health systems: a review. J Intern Med. 2021;289:450–62. https://doi.org/10.1111/JOIM.13184.
13. Creech CB, Walker SC, Samuels RJ. SARS-CoV-2 vaccines. JAMA. 2021;325:1318–20. https://doi.org/10.1001/JAMA.2021.3199.